Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry

ConclusionsThe results of this real-world study provide insight into the demographic and clinical characteristics of patients with AS who discontinue vs. continue TNFi therapy in US clinical practice.FundingCorrona, LLC.Plain Language SummaryPlain language summary available for this article.

Source: Rheumatology and Therapy - October 23, 2018 Category: Rheumatology Source Type: research